The Safety, Efficacy, and Potential Complications of Intracameral Antibiotics
- 38 Downloads
Purpose of Review
The use of intracameral antibiotics (ICAs) as endophthalmitis prophylaxis after cataract surgery has increased in the past decade. The goal of this paper is to review the current literature arguing for and against ICAs.
There is compelling evidence that ICAs have greater efficacy than topical antibiotics in preventing post-operative endophthalmitis. However, issues related to availability, cost, and safety have limited their widespread adoption in countries such as the USA.
In countries without access to a commercially available prepackaged antibiotic for intracameral use, cataract surgeons will have to individually weigh the risks and benefits of ICAs in determining their method of endophthalmitis prophylaxis.
KeywordsIntracameral antibiotics Cataract surgery Endophthalmitis Hemorrhagic occlusive retinal vasculitis
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
- 4.Grzybowski A, Kuklo P, Pieczynski J, Beiko G. A review of preoperative manoeuvres for prophylaxis of endophthalmitis in intraocular surgery: topical application of antibiotics, disinfectants, or both? Curr Opin Ophthalmol. 2016;27(1):9–23. https://doi.org/10.1097/ICU.0000000000000216.CrossRefPubMedGoogle Scholar
- 7.Endophthalmitis Study Group ESoC. Refractive S. Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg. 2007;33(6):978–88. https://doi.org/10.1016/j.jcrs.2007.02.032.CrossRefGoogle Scholar
- 8.Chang DF, Braga-Mele R, Henderson BA, Mamalis N, Vasavada A, Committee ACC. Antibiotic prophylaxis of postoperative endophthalmitis after cataract surgery: results of the 2014 ASCRS member survey. J Cataract Refract Surg. 2015;41(6):1300–5. https://doi.org/10.1016/j.jcrs.2015.01.014.CrossRefPubMedGoogle Scholar
- 15.Linertova R, Abreu-Gonzalez R, Garcia-Perez L, Alonso-Plasencia M, Cordoves-Dorta LM, Abreu-Reyes JA, et al. Intracameral cefuroxime and moxifloxacin used as endophthalmitis prophylaxis after cataract surgery: systematic review of effectiveness and cost-effectiveness. Clin Ophthalmol. 2014;8:1515–22. https://doi.org/10.2147/OPTH.S59776.CrossRefPubMedPubMedCentralGoogle Scholar
- 22.Administration USFD. Compounded Triamicinolone and Moxifloxacin Product for Intravitreal Injection by Guardian Pharmacy Services: Alert to Health Professionals - Serious Adverse Events Reported. 2017. https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm569123.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery. Accessed October 24th, 2017.
- 23.Administration USFD. A case of hemorrhagic occlusive retinal vasculitis (HORV) following intraocular injections of a compounded triamcinolone, moxifloxacin, and vancomycin formulation. https://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/PharmacyCompounding/ucm578514.htm. Accessed 7 February 2018.
- 24.Todorich B. New Insights in Vancomycin-associated Hemorrhagic Occlusive Retinal Vasculopathy (HORV). Retina Society Annual Meeting; Boston, MA October 5, 2017.Google Scholar